199 related articles for article (PubMed ID: 17077101)
1. Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis.
Gafter-Gvili A; Paul M; Fraser A; Leibovici L
J Antimicrob Chemother; 2007 Jan; 59(1):5-22. PubMed ID: 17077101
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.
Gafter-Gvili A; Fraser A; Paul M; van de Wetering M; Kremer L; Leibovici L
Cochrane Database Syst Rev; 2005 Oct; (4):CD004386. PubMed ID: 16235360
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.
Gafter-Gvili A; Fraser A; Paul M; Vidal L; Lawrie TA; van de Wetering MD; Kremer LC; Leibovici L
Cochrane Database Syst Rev; 2012 Jan; 1(1):CD004386. PubMed ID: 22258955
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.
Engels EA; Lau J; Barza M
J Clin Oncol; 1998 Mar; 16(3):1179-87. PubMed ID: 9508206
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients.
Gafter-Gvili A; Fraser A; Paul M; Leibovici L
Ann Intern Med; 2005 Jun; 142(12 Pt 1):979-95. PubMed ID: 15968013
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: a systematic review of randomised controlled trials.
van de Wetering MD; de Witte MA; Kremer LC; Offringa M; Scholten RJ; Caron HN
Eur J Cancer; 2005 Jul; 41(10):1372-82. PubMed ID: 15913983
[TBL] [Abstract][Full Text] [Related]
7. Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis.
Prabhu RM; Piper KE; Litzow MR; Steckelberg JM; Patel R
Eur J Clin Microbiol Infect Dis; 2005 Dec; 24(12):832-8. PubMed ID: 16331335
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials.
Green H; Paul M; Vidal L; Leibovici L
Mayo Clin Proc; 2007 Sep; 82(9):1052-9. PubMed ID: 17803871
[TBL] [Abstract][Full Text] [Related]
9. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.
Playford EG; Webster AC; Sorrell TC; Craig JC
J Antimicrob Chemother; 2006 Apr; 57(4):628-38. PubMed ID: 16459344
[TBL] [Abstract][Full Text] [Related]
10. Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials.
Paul M; Borok S; Fraser A; Vidal L; Leibovici L
J Antimicrob Chemother; 2005 Apr; 55(4):436-44. PubMed ID: 15722392
[TBL] [Abstract][Full Text] [Related]
11. Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance.
Garnica M; Nouér SA; Pellegrino FL; Moreira BM; Maiolino A; Nucci M
BMC Infect Dis; 2013 Jul; 13():356. PubMed ID: 23899356
[TBL] [Abstract][Full Text] [Related]
12. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials.
Vidal L; Paul M; Ben dor I; Soares-Weiser K; Leibovici L
J Antimicrob Chemother; 2004 Jul; 54(1):29-37. PubMed ID: 15201227
[TBL] [Abstract][Full Text] [Related]
13. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
14. Protecting neutropenic patients from bowel-derived organisms.
Warren RE
J Hosp Infect; 1991 Sep; 19 Suppl C():43-58. PubMed ID: 1684195
[TBL] [Abstract][Full Text] [Related]
15. Quinolone prophylaxis in neutropenic patients - efficacy versus resistance.
Nucci M; Pulcheri W; Spector N; Bueno A; Silveira S; Marangoni D; Ferreira R; Deoliveira H
Oncol Rep; 1994 Nov; 1(6):1101-5. PubMed ID: 21607499
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Antibiotic Stewardship Programs in Combating Quinolone Resistance: A Systematic Review and Recommendations for More Efficient Interventions.
Pitiriga V; Vrioni G; Saroglou G; Tsakris A
Adv Ther; 2017 Apr; 34(4):854-865. PubMed ID: 28303388
[TBL] [Abstract][Full Text] [Related]
17. Use of the quinolones in the prophylaxis and treatment of granulocytopenic immunocompromised cancer patients.
Van der Auwera P; Gérain J
Drugs; 1993; 45 Suppl 3():81-90. PubMed ID: 7689457
[TBL] [Abstract][Full Text] [Related]
18. Use of the quinolones for the prophylaxis and therapy of infections in immunocompromised hosts.
Maschmeyer G
Drugs; 1993; 45 Suppl 3():73-80. PubMed ID: 7689455
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic prophylaxis for patients with acute leukemia.
Hammond SP; Baden LR
Leuk Lymphoma; 2008 Feb; 49(2):183-93. PubMed ID: 18231904
[TBL] [Abstract][Full Text] [Related]
20. Fosfomycin vs. quinolone-based antibiotic prophylaxis for transrectal ultrasound-guided biopsy of the prostate: a systematic review and meta-analysis.
Noreikaite J; Jones P; Fitzpatrick J; Amitharaj R; Pietropaolo A; Vasdev N; Chadwick D; Somani BK; Rai BP
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):153-160. PubMed ID: 29487398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
